您的位置: 首页 > 2022年9月 第52卷 第5期 > 文字全文
2023年7月 第38卷 第7期11
目录

来曲唑和氯米芬治疗极严重少精子症的疗效分析

Efficacy of letrozole and clomiphene in the treatment of extremely severe oligospermia

来源期刊: 广州医药 | 105-108 发布时间:2022-10-11 收稿时间:2025/11/13 18:18:26 阅读量:14
作者:
关键词:
来曲唑氯米芬极严重少精子症
letrozoleclomeipheneextremely oligospermia
DOI:
10.3969/j.issn.1000-8535.2022.05.022
收稿时间:
2022-01-21 
修订日期:
 
接收日期:
 
引用总数:
0  
目的 比较来曲唑和氯米芬治疗极严重少精子症的治疗效果。方法 选取2020—2021年在本生殖中心门诊50例极严重少精子症病例,分为2组,A组(来曲唑,研究组n=26)、B组(氯米芬,对照组n=24)。结果 来曲唑和氯米芬治疗后1月、3月,A组精子浓度明显提高,优于B组[(4.5±3.1) vs (2.0±1.3);(8.3±3.5) vs (2.0±1.8),P<0.05]。通过卵胞浆内单精子注射/体外受精胚胎移植治疗,A组妊娠16例(61.5%),B组妊娠11例(45%)。2组治疗后的血清卵泡刺激素、黄体生成素、睾酮升高[(5.9±3.8) vs (20.3±2.6);(3.6±2.8) vs (9.5±5.7);(13.6±10.5) vs (25.3±10.8),P<0.05],A组雌二醇水平降低[(36.8±20.6) vs (7.6±2.5),P<0.05]。结论 来曲唑治疗极严重少精子症有较理想的临床治疗效果,明显优于氯米芬。
Objective To explore and compare the therapeutic effects of letrozole and clomiphene in the treatment of extremely severe oligospermia. Methods A tatal of 50 cases of extremely severe oligosperospermia in the reproductive center from 2020 to 2021 were selected and divided into two groups, group A (letrozole, study group n=26) and B (clomiphene, control group n=24). Results After letrizole and clomiphene treated for 1 and 3 months, sperm concentration in group A was significantly better than group B[(4.5±3.1) vs (2.0±1.3);(8.3±3.5) vs (2.0±1.8),P<0.05]. With ICSI/IVF, 16 cases (61.5%) succeed in encyesis in group A, 11 cases (45%) in group B. Serum follicle stimulating hormone, luteinizing hormone and testosterone levels were significantly increased after treatment [(5.9±3.8) vs (20.3±2.6), (3.6±2.8) vs (9.5±5.7), (13.6±10.5) vs (25.3±10.8), P<0.05]. The level of estradiol in group A decreased [(36.8±20.6) vs (7.6±2.5), P<0.05]. Conclusions Letrozole has ideal clinical treatment effect, which is obviously superior to clommiphene.
1、 李海露,王瑞,王卫星,等. 男性性欲与血清生殖激素水平相关性分析[J].中华男科学杂志,2019,25(6):509-513. 李海露,王瑞,王卫星,等. 男性性欲与血清生殖激素水平相关性分析[J].中华男科学杂志,2019,25(6):509-513.
2、 王宇宁,魏文杨,宋焱鑫,等. 来曲唑联合复方玄驹胶囊治疗肥胖性少弱精子症的临床疗效观察[J].生殖医学杂志,2021,4,30(4):509-513. 王宇宁,魏文杨,宋焱鑫,等. 来曲唑联合复方玄驹胶囊治疗肥胖性少弱精子症的临床疗效观察[J].生殖医学杂志,2021,4,30(4):509-513.
3、 田芙颖,刁瑞英,镇万华,等. 来曲唑治疗男性少弱精子症的临床研究[J].中国计划生育学杂志,2016,24(9):606-609. 田芙颖,刁瑞英,镇万华,等. 来曲唑治疗男性少弱精子症的临床研究[J].中国计划生育学杂志,2016,24(9):606-609.
4、 MILLER G D,MOORE C,NAIR V,et al. Hypothalamic pituitary testicular axiseffects and urinarydetection following clomiphene administrztion in males[J].J Clin Endocrinol Metab,2019,104(3):906-914. MILLER G D,MOORE C,NAIR V,et al. Hypothalamic pituitary testicular axiseffects and urinarydetection following clomiphene administrztion in males[J].J Clin Endocrinol Metab,2019,104(3):906-914.
5、 蒲江波,李雪梅,朱文杰,等. 绒促性素联合小剂量雄激素治疗少精子及弱精子症效果观查[J].山东医学,20116,56(30):89-91. 蒲江波,李雪梅,朱文杰,等. 绒促性素联合小剂量雄激素治疗少精子及弱精子症效果观查[J].山东医学,20116,56(30):89-91.
6、 欧阳海,谭艳,谢胜,等. 来曲唑在非梗阻性无精子症中应用效果研究[J].生殖医学杂志,2017,26(10):989-994. 欧阳海,谭艳,谢胜,等. 来曲唑在非梗阻性无精子症中应用效果研究[J].生殖医学杂志,2017,26(10):989-994.
7、 CAVALLINI G,BIAGIOTTI G,BOLZON E. Multivariate analysi s to predict letrozol eefficacy in improving sperm count of nonobst ructive azoospermic and cryptozoospermic patients:a pilot study[J]. Asian J Androl,2013,15(6):806-811. CAVALLINI G,BIAGIOTTI G,BOLZON E. Multivariate analysi s to predict letrozol eefficacy in improving sperm count of nonobst ructive azoospermic and cryptozoospermic patients:a pilot study[J]. Asian J Androl,2013,15(6):806-811.
8、 PATRY G, JARVI K, GROBER E D,et al. Use of the aromatase inhibitor letrozole to treat male infertility[J]. Fertil Steril,2009,92(2):829. E1-2. PATRY G, JARVI K, GROBER E D,et al. Use of the aromatase inhibitor letrozole to treat male infertility[J]. Fertil Steril,2009,92(2):829. E1-2.
9、 李宏军.芳香化酶抑制剂在男性不育治疗中的应用[J].生殖医学杂志,2015,24(7):597-600. 李宏军.芳香化酶抑制剂在男性不育治疗中的应用[J].生殖医学杂志,2015,24(7):597-600.
10、 白双勇,王剑松,赵庆华.重组人生长激素联合来曲唑治疗肥胖男性少弱精子症疗效分析[J].中华男科学杂志,2015,21(3):280-282. 白双勇,王剑松,赵庆华.重组人生长激素联合来曲唑治疗肥胖男性少弱精子症疗效分析[J].中华男科学杂志,2015,21(3):280-282.
11、 侯建文,孟祥黔.单精子冷冻研究进展[J].中华男科学杂志,2018,24(5):447-451. 侯建文,孟祥黔.单精子冷冻研究进展[J].中华男科学杂志,2018,24(5):447-451.
12、 PISARSKA M D,CHAN J L,LAWRENSON K,et al.Genetics and epigenetics of infertility and treatments on outcomes[J].J Clin Endocrinol Metab,2019,104(6):1871-1886. PISARSKA M D,CHAN J L,LAWRENSON K,et al.Genetics and epigenetics of infertility and treatments on outcomes[J].J Clin Endocrinol Metab,2019,104(6):1871-1886.
13、 CAVALLINI G, BERETTA G, BIAGIOTTI G.Preliminary study of letrozole use for improving spermatogenesis in non-obstructive azoospermia patients with normal serum FSH[J]. Asian J Androl,2011,13(6):895-857. CAVALLINI G, BERETTA G, BIAGIOTTI G.Preliminary study of letrozole use for improving spermatogenesis in non-obstructive azoospermia patients with normal serum FSH[J]. Asian J Androl,2011,13(6):895-857.
14、 陈振文.辅助生殖男性技术 [M].北京:人民卫生出版社,2016. 陈振文.辅助生殖男性技术 [M].北京:人民卫生出版社,2016.
15、 李定明,刘博,鲜泱.不同浓度稀少精子冷冻技术效果的观察 [J].中华男科学杂志, 2018,24(5):447-451. 李定明,刘博,鲜泱.不同浓度稀少精子冷冻技术效果的观察 [J].中华男科学杂志, 2018,24(5):447-451.
16、 马媛,海溧,陈书强.男方畸形精子症对胚胎植入前遗传学筛查患者胚胎非整倍体及胚胎发育指标的影响 [J].中国妇产科临床杂志,2018,24 (8):705-707. 马媛,海溧,陈书强.男方畸形精子症对胚胎植入前遗传学筛查患者胚胎非整倍体及胚胎发育指标的影响 [J].中国妇产科临床杂志,2018,24 (8):705-707.
17、 冯强,马志伟,王寓.男性不育症患者生殖支原体感染与精液常规参数及精子DNA完整性的相关性 [J].中华男科学杂志,2020,26(10):900-905. 冯强,马志伟,王寓.男性不育症患者生殖支原体感染与精液常规参数及精子DNA完整性的相关性 [J].中华男科学杂志,2020,26(10):900-905.
18、 王阳,李伟鹏,李政.芳香化酶抑制剂治疗男性不育症的研究进展 [J].中华泌尿外科杂志,2019,40(10):798-800. 王阳,李伟鹏,李政.芳香化酶抑制剂治疗男性不育症的研究进展 [J].中华泌尿外科杂志,2019,40(10):798-800.
上一篇
下一篇
出版者信息








《广州医药》公众号
目录